Heliyon,
Journal Year:
2024,
Volume and Issue:
10(6), P. e27655 - e27655
Published: March 1, 2024
Cancer
is
a
complex
disease
that
caused
by
multiple
genetic
factors.
Researchers
have
been
studying
protein
domain
mutations
to
understand
how
they
affect
the
progression
and
treatment
of
cancer.
These
can
significantly
impact
development
spread
cancer
changing
structure,
function,
signalling
pathways.
As
result,
there
growing
interest
in
these
be
used
as
prognostic
indicators
for
prognosis.
Recent
studies
shown
provide
valuable
information
about
severity
patient's
response
treatment.
They
may
also
predict
resistance
targeted
therapy
The
clinical
implications
are
significant,
regarded
essential
biomarkers
oncology.
However,
additional
techniques
approaches
required
characterize
changes
domains
their
functional
effects.
Machine
learning
other
computational
tools
offer
promising
solutions
this
challenge,
enabling
prediction
on
structure
function.
Such
predictions
aid
interpretation
information.
Furthermore,
genome
editing
like
CRISPR/Cas9
has
made
it
possible
validate
significance
mutants
more
efficiently
accurately.
In
conclusion,
hold
great
promise
predictive
Overall,
considerable
research
still
needed
better
define
molecular
heterogeneity
resolve
challenges
remain,
so
full
potential
realized.
Proceedings of the National Academy of Sciences,
Journal Year:
2025,
Volume and Issue:
122(11)
Published: March 14, 2025
Dynamic
processes
involving
biomolecules
are
essential
for
the
function
of
cell.
Here,
we
introduce
an
integrative
method
computing
models
these
based
on
multiple
heterogeneous
sources
information,
including
time-resolved
experimental
data
and
physical
dynamic
processes.
First,
each
time
point,
a
set
coarse
compositional
structural
heterogeneity
is
computed
(heterogeneity
models).
Second,
model,
static
structure
(a
snapshot
model).
Finally,
selected
connected
into
series
trajectories
that
optimize
likelihood
both
transitions
between
them
trajectory
The
demonstrated
by
application
to
assembly
process
human
nuclear
pore
complex
in
context
reforming
envelope
during
mitotic
cell
division,
live-cell
correlated
electron
tomography,
bulk
fluorescence
correlation
spectroscopy–calibrated
quantitative
live
imaging,
model
fully
assembled
complex.
Modeling
improves
precision
over
modeling
alone.
applicable
wide
range
time-dependent
systems
biology
available
broader
scientific
community
through
implementation
open
source
Integrative
Platform
(IMP)
software.
Journal of Proteome Research,
Journal Year:
2021,
Volume and Issue:
20(3), P. 1792 - 1801
Published: Feb. 23, 2021
Multiplexed
quantitative
proteomics
enabled
complex
workflows
to
study
the
mechanisms
by
which
small
molecule
drugs
interact
with
proteome
such
as
thermal
profiling
(TPP)
or
multiplexed
dynamics
(mPDP).
TPP
measures
changes
in
protein
stability
response
drug
treatment
and
thus
informs
on
direct
targets
downstream
regulation
events,
while
mPDP
approach
enables
discovery
of
regulated
synthesis
degradation
events
caused
molecules
other
perturbations.
The
isobaric
mass
tags
available
for
have
far
limited
efficiency
sensitivity
experiments
could
be
performed.
Here
we
evaluate
a
recent
generation
16-plex
demonstrate
sensitive
time
efficient
identification
Staurosporine
HepG2
cell
extracts
recording
full
denaturation/aggregation
profiles
vehicle
compound
treated
samples
single
spectrometry
experiment.
In
2D-TPP
experiments,
isothermal
titration
over
seven
concentrations
per
temperature
comprehensive
selectivity
EC50
values
kinase
tightly
matching
kinobeads
gold
standard
assay.
Finally,
condition-based
multiplexing
dynamic
SILAC
labeling
delineate
proteome-wide
effects
molecular
glue
Indisulam
rates.
Trends in Pharmacological Sciences,
Journal Year:
2023,
Volume and Issue:
44(11), P. 786 - 801
Published: Sept. 29, 2023
Targeted
protein
degradation
(TPD)
is
an
emerging
modality
for
research
and
therapeutics.
Most
TPD
approaches
harness
cellular
ubiquitin-dependent
proteolytic
pathways.
Proteolysis-targeting
chimeras
(PROTACs)
molecular
glue
(MG)
degraders
(MGDs)
represent
the
most
advanced
approaches,
with
some
already
used
in
clinical
settings.
Despite
these
advances,
still
faces
many
challenges,
pertaining
to
both
development
of
effective,
selective,
tissue-penetrant
understanding
their
mode
action.
In
this
review,
we
focus
on
progress
made
addressing
challenges.
particular,
discuss
utility
application
recent
proteomic
as
indispensable
tools
enable
insights
into
degrader
development,
including
target
engagement,
selectivity,
efficacy,
safety,
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: April 30, 2024
Abstract
Abberent
protein-protein
interactions
potentiate
many
diseases
and
one
example
is
the
toxic,
self-assembly
of
α-Synuclein
in
dopaminergic
neurons
patients
with
Parkinson’s
disease;
therefore,
a
potential
therapeutic
strategy
small
molecule
modulation
aggregation.
In
this
work,
we
develop
an
Oligopyridylamide
based
2-dimensional
Fragment-Assisted
Structure-based
Technique
to
identify
antagonists
The
technique
utilizes
fragment-based
screening
extensive
array
non-proteinogenic
side
chains
Oligopyridylamides,
leading
identification
NS132
as
antagonist
multiple
facets
We
further
more
cell
permeable
analog
(NS163)
without
sacrificing
activity.
Oligopyridylamides
rescue
aggregation
mediated
disease
phenotypes
early
post
Caenorhabditis
elegans
models.
forsee
tremendous
our
lead
therapeutics
for
other
it
expandable
oligoamide
scaffolds
larger
chains.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Dec. 4, 2023
Abstract
Understanding
how
small
molecules
bind
to
specific
protein
complexes
in
living
cells
is
critical
understanding
their
mechanism-of-action.
Unbiased
chemical
biology
strategies
for
direct
readout
of
interactome
remodelling
by
would
provide
advantages
over
target-focused
approaches,
including
the
ability
detect
previously
unknown
ligand
targets
and
complexes.
However,
there
are
few
current
methods
unbiased
profiling
molecule
interactomes.
To
address
this,
we
envisioned
a
technology
that
combine
sensitivity
live-cell
compatibility
proximity
labelling
coupled
mass
spectrometry,
with
specificity
nature
chemoproteomics.
In
this
manuscript,
describe
BioTAC
system,
small-molecule
guided
platform
can
rapidly
identify
both
complexed
binding
proteins.
We
benchmark
system
against
µMap,
photoaffinity
labelling,
affinity
purification
spectrometry
datasets.
also
apply
maps
Trametinib
analogues.
The
overcomes
limitation
approaches
supports
identification
inhibitor
bound
molecular
glue
Computational and Structural Biotechnology Journal,
Journal Year:
2024,
Volume and Issue:
23, P. 742 - 751
Published: Jan. 18, 2024
Peroxidases
are
essential
elements
in
many
biotechnological
applications.
An
especially
interesting
concept
involves
split
enzymes,
where
the
enzyme
is
separated
into
two
smaller
and
inactive
proteins
that
can
dimerize
a
fully
active
enzyme.
Such
forms
were
developed
for
horseradish
peroxidase
(HRP)
ascorbate
(APX)
already.
Both
peroxidases
have
high
potential
biotechnology
In
present
study,
we
performed
biophysical
comparisons
of
these
their
analogues.
The
site
availability
similar
all
four
structures.
enzymes
comparable
stability
with
native
analogues,
meaning
they
be
used
further
Also,
tertiary
structures
similar.
However,
differences
might
help
choosing
one
system
over
another
applications
noticed.
main
difference
between
systems
glycosylation
which
not
case
APX/sAPEX2,
while
it
has
impact
on
HRP/sHRP
stability.
Further
calcium
ions
cysteine
bridges
only
HRP/sHRP.
Finally,
computational
results
identified
sAPEX2
as
smallest
structural
variations
during
molecular
dynamics
simulations
showing
its
dominant
comparing
to
other
simulated
proteins.
Taken
together,
due
lack
glycans
cysteines,
well